Daptomycin: Began Phase III study

Cubist Pharmaceuticals Inc. (CBST), Cambridge, Mass. Product: Daptomycin Business: Infectious diseases Therapeutic category: Bacterial infection Target: Cell walls of gram positive bacteria Descriptio...